Gamitrinib-TPP
CAS: 1131626-47-5
Ref. 3D-GVB62647
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Información del producto
Gamitrinib-TPP is a synthetic drug that was developed to target cancer cells. It has been shown to have an activated form that binds to mitochondria and inhibits the mitochondrial membrane potential, which is necessary for the production of ATP. The drug also targets chaperones, which are proteins that assist in protein folding and regulation. Gamitrinib-TPP has been shown to inhibit stem cell-like features in cancerous cells. This drug also induces autophagy, which is a process where damaged proteins are broken down for energy production. Gamitrinib-TPP is composed of ornithine and TPP covalently bound together by a disulfide bond.
Propiedades químicas
Consulta técnica sobre: 3D-GVB62647 Gamitrinib-TPP
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
